Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Apr. 30, 2023	Apr. 30, 2022
Income Statement [Abstract]
Net sales	$ 219,494	$ 168,872
Cost of products sold	183,906	144,652
Gross profit	35,588	24,220
Operating expenses	30,224	26,828
Operating earnings (loss)	5,364	(2,608)
Pension (expense) income	(71)	355
Other income, net	939	400
Interest expense	(1,734)	(632)
Earnings (Loss) before income taxes	4,498	(2,485)
Income tax expense	3,139	3,518
Net earnings (loss)	1,359	(6,003)
Less: net earnings attributable to the non-controlling interest	621	123
Net earnings (loss) attributable to Kewaunee Scientific Corporation	$ 738	$ (6,126)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in usd per share)	$ 0.26	$ (2.20)
Diluted (in usd per share)	$ 0.25	$ (2.20)
Weighted average number of common shares outstanding
Basic (in shares)	2,824	2,786
Diluted (in shares)	2,902	2,786

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227